Study of C-reactive protein and procalcitonin in detecting subclinical intrauterine infections in preterm prelabour rupture of membrane
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262524Keywords:
C-Reactive protein, Intrauterine infection, Preterm premature rupture of membranes, ProcalcitoninAbstract
Background: Chorioamnionitis or intrauterine infection contributes to approximately 40–50% of preterm deliveries. Clinical signs appear late and are subjective, while conventional investigations such as leukocyte count and cultures are either unreliable or time consuming. Histopathological examination of the placenta confirms the diagnosis only after delivery. This study assessed C-reactive protein (CRP) and procalcitonin (PCT) in detecting subclinical intrauterine infection in women with preterm prelabour rupture of membranes (PPROM).
Methods: This cross-sectional study included 40 women with singleton pregnancies complicated by PPROM between 28 and 36+6 weeks of gestation at Hindu Rao Hospital over one year. Women with leaking per vaginum for more than12 hours were enrolled. CRP and PCT levels were measured at admission and delivery. Their association with clinical and histopathological chorioamnionitis was analyzed using SPSS version 25.0, and ROC curves determining optimal cut-off values.
Results: The mean age was 25.12±3.7 years, and mean gestational age was 34.98±1.38 weeks. Clinical chorioamnionitis occurred in 80% and histopathological chorioamnionitis in 55% of cases, with risk increasing significantly as leaking duration per vaginum prolonged. CRP was found to be a better predictor than PCT. CRP at termination predicted clinical chorioamnionitis at a cut-off >15.6 mg/l (AUC 0.805), whereas CRP on admission predicted histopathological chorioamnionitis at a cut-off >12 mg/l (AUC 0.941).
Conclusions: CRP and PCT are valuable biomarkers for early intrauterine infection detection in PPROM, enabling timely treatment and improving maternal-neonatal outcomes.
References
Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM, et al. Management of obstetrical haemorrhage. In: Williams Obstetrics, 26th ed. New York, NY: Mc Grow Hill; 2022:2025-26.
Borah SI, Das GC, Deori L. Role of CRP (C-Reactive Protein) in clinical outcome in patient with PPROM. New Ind J OBGYN. 2017; 4(1):17-21.
Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM, et al. Preterm birth. In: Williams Obstetrics. 26th ed. New York, NY: McGraw-Hill; 2022:2038-2055.
Evans MI, Hajj SN, Devoe LD, Angerman NS, Moawad AH. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes. Am J Obstet Gynecol. 1980;138(6):648.
Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med. 1999;27:5-20.
Czikk MJ, McCarthy FP, Murphy KE. Chorioamnionitis: From pathogenesis to treatment. Clin Microbiol Infect. 2011;17(9):1304-11.
Smith EJ, Muller CL, Sartorius JA, White DR, Maslow AS. C Reactive protein as a predictor of chorioamnionitis. J Am Osteopath Assoc. 2012;112(10):660-4.
Bell SG. Procalcitonin and neonatal sepsis: Is this the biomarker we are looking for? Neonatal Netw. 2017;36(6):380-4.
Thornburg LL, Queenan R, Brandt–Griffith B. Pressman EK. Procalcitonin for prediction of chorioamnionitis in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2016;29(13):2056.
Tujula B, Kokki H, Rasanen J, Kokki M. Procalcitonin; a feasible biomarker for severe bacterial infections in Obstetrics and Gynecology? Acta Obstet Gynecol Scan. 2018;97(5):505.
Li K, Yu H, Wang X, Liu X. Predictive value of procalcitonin or c-reactive protein for subclinical intrauterine infection in patients with premature rupture of membranes. J Prenat Medi. 2016;10(3-4):23-8.
Tsakiridis I, Mamopoulos A, Chalkia-Prapa EM, Athanasiadis A, Dagklis T. Preterm premature rupture of membranes; A review of 3 national guidelines. Obstet Gynecol Surv. 2018;73(6):368-75.
Yoon BH, Romero R, Park JS. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182(3):675-81.
Salafia CM, Minior VK, Rosenkrantz TS. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks’ gestation. Am J Perinatol. 1995;12(06):429-36.
Carroll SG. Preterm prelabour rupture of membranes. Green Top Guideline No. 44. Royal College of Obstetricians and Gynaecologists, 2006 (Minor amendment October 2010).
Baker RZ, Koroglu N, Turkgeldi LS, Tola E N, Cetin B A, Gedikbasi A. Maternal serum procalcitonin level in prediction of chorioamnionitis in women with preterm premature rupture of membranes. Arch Med Sci. 2021;17(3):694-9.
Dayal S, M SJ, Hong PL. Preterm and term prelabor rupture of membranes. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024.
Chew KS. What’s new in emergencies trauma and shock? C-reactive protein as a potential clinical biomarker for influenza infection: More questions than answers. J Emerg Trauma Shock. 2012;5(2):115-7.
ACOG committee practice bulletin. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109(4):1007-19.
Aggarwal A, Pahwa S. Evaluation of the role of CRP as an early predictor of chorioamnionitis in PPROM. Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1351-6.
Asadi N, Faraji A, Keshavarzi A, Akbarzadeh-Jahromi M, Yoosefi S. Predictive value of procalcitonin, C-reactive protein, and white blood cells for chorioamnionitis among women with preterm premature rupture of membranes. Int J Gynecol Obstet. 2019;147(1):83-8.
Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol. 2005;162(11):1108-13.
Wang Y, Xu Y, Wang S, Wang X, Gu Y, Zhang Y. Prediction of intrauterine inflammation in patients with preterm premature rupture of membranes at 28 to 34 weeks of gestation. Clin Exp Obstet Gynecol. 2022;49(2):042.
Downloads
Published
How to Cite
Issue
Section
